Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com

by · The Markets Daily

StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Athersys has a 1 year low of $0.01 and a 1 year high of $1.99. The firm has a market capitalization of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.

Athersys Company Profile

(Get Free Report)

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.

See Also